Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Recurso digital |
| Hizkuntza: | |
| Argitaratua: |
Zenodo
2025
|
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.5281/zenodo.17841198 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
| _version_ | 1866901765206573056 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Patients taking dronedarone and rivaroxaban should have regular cardiac and liver function monitoring, with vigilance for bleeding risks, given the potential for increased bleeding when these drugs are combined. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17841198 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | What monitoring is recommended for patients taking both dronedarone and rivaroxaban? Tripdatabase monitoring recommended patients taking both dronedarone rivaroxaban Patients taking dronedarone and rivaroxaban should have regular cardiac and liver function monitoring, with vigilance for bleeding risks, given the potential for increased bleeding when these drugs are combined. |
| title | What monitoring is recommended for patients taking both dronedarone and rivaroxaban? |
| topic | monitoring recommended patients taking both dronedarone rivaroxaban |
| url | https://doi.org/10.5281/zenodo.17841198 |